跳至主要内容
临床试验/NCT03468348
NCT03468348已完成不适用

Duloxetine for Acute Post-mastectomy Pain: Placebo Controlled Dose Ranging Study

Assiut University1 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2018年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
88
试验地点
1
主要终点
the first postoperative 24 h (patient controlled analgesia [PCA])morphine consumption

研究概览

简要总结

The objective of this study is to evaluate the analgesic effect of oral dulexitine tablet (administered 2 h before surgery) as well as the ideal dose for acute postmastectomy pain.

详细描述

patients undergoing mastectomy with axillary evacuation will be divided to four groups, Placebo group: received placebo capsule Duloxetine 30: received duloxetine 30 mg capsule Duloxetine 60: received duloxetine 60 mg capsule Duloxetine 90: received duloxetine 90 mg capsule the study medication is administered orall 2 h before surgery. Primary outcome variable: the first postoperative 24 h morphine consumption Secondary outcome: the VAS pain score measured every 4 h in the first 24 h postoperatively.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Adult females scheduled for unilateral MRM with axillary evacuation for breast cancer,
  • American Society of Anesthesiologists physical status (ASA) class I and II

排除标准

  • Patients with a known allergy to Duloxetine or morphine,
  • A history of drug or alcohol abuse,
  • Patients with impaired kidney or liver functions,
  • Patients with chronic pain or regularly receiving analgesics,
  • Any psychiatric illness that would interfere with the perception and the assessment of pain.
  • Any reason that resulted in the protocol violation.

研究组 & 干预措施

placebo group

Placebo Comparator

干预措施: Duloxetine (Drug)

duloxetine 30

Active Comparator

干预措施: Duloxetine (Drug)

duloxetine 60

Active Comparator

干预措施: Duloxetine (Drug)

duloxetine 90

Active Comparator

干预措施: Duloxetine (Drug)

结局指标

主要结局

the first postoperative 24 h (patient controlled analgesia [PCA])morphine consumption

时间窗: the first postoperative 24 hour

the cumulative patient controlled analgesia morphine consumption required by the patients to relieve their pain in the first postoperative 24 h

次要结局

  • The level of consciousness assessed by "the Modified Ramsay Sedation score"(the score will be measured at 8 hour, 16 hour and 24 hour postoperatively)
  • The occurrence of vomiting(The outcome will be obtained once 24 hour postoperatively)
  • The intensity of pain measured by visual analogue pain scale (VAS)(The outcome will be assessed at 0 hour, 2 hour, 4 hour,8 hour, 16 hour and 24 hour postoperatively.)
  • The quality of postoperative recovery, assessed by "The QoR-40 questionnaire" (the quality of recovery-40 questionnaire)(the questionnair will be assessed once, 24 hour postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Diab Fuad Hetta

principle investigator

Assiut University

研究点 (1)

Loading locations...

相似试验